PUBLISHER: Blueweave Consulting | PRODUCT CODE: 1584757
PUBLISHER: Blueweave Consulting | PRODUCT CODE: 1584757
United States Hospital and Nursing Home Probiotics Market, By Product Type; By Formulation; By Application; By Distribution Channel, Trend Analysis, Competitive Landscape & Forecast, 2019-2030
United States Hospital and Nursing Home Probiotics Market Expands at 9.1% CAGR to Touch USD 198 Million by 2030
United States Hospital and Nursing Home Probiotics Market is thriving due to rising healthcare awareness, an increasing demand for gut health management among growing elderly population, and a heightened focus on preventive healthcare solutions.
BlueWeave Consulting, a leading strategic consulting, and Market research firm, in its recent study, estimated United States Hospital and Nursing Home Probiotics Market size by value at USD 110.20 million in 2023. During the forecast period between 2024 and 2030, BlueWeave expects United States Hospital and Nursing Home Probiotics Market size to expand at a CAGR of 9.10% reaching a value of USD 197.76 million by 2030. Major driving factors for United States Hospital and Nursing Home Probiotics Market include growing awareness about the health benefits of probiotics in enhancing digestive and immune system health. A spurring demand for preventive healthcare, the rising prevalence of gastrointestinal disorders, and the need to reduce antibiotic overuse are contributing factors. Additionally, the elderly population's increased susceptibility to infections and gut health issues, along with the expanding adoption of probiotics in clinical settings, further support market growth in hospitals and nursing homes across the United States.
Opportunity - Improved Patient Outcomes
An increasing focus on enhancing patient outcomes is a key growth driver for United States Hospital and Nursing Home Probiotics Market. Probiotics are increasingly recognized for their role in preventing hospital-acquired infections, improving gut health, and boosting immune function. These benefits, combined with a growing emphasis on personalized care, are leading healthcare providers to integrate probiotics into treatment plans, especially for elderly and immunocompromised patients, thereby driving demand in hospitals and nursing homes.
Impact of Escalating Geopolitical Tensions on United States Hospital and Nursing Home Probiotics Market
Escalating geopolitical tensions could disrupt global supply chains, leading to shortages and increased costs for probiotics in United States Hospital and Nursing Home Markets. Consequently, affecting the availability of the products and the profit margins of market players. Trade restrictions, tariffs, and shipping delays could affect the availability of raw materials and finished probiotic products. Additionally, heightened uncertainty may prompt healthcare providers to prioritize essential supplies over probiotics, potentially impacting market demand. Regulatory changes and currency fluctuations could further influence product pricing, creating challenges for manufacturers and distributors in the United States Hospital and Nursing Home Probiotics Market.
Capsule/Tablet Formulations Hold Largest Market Share
The capsules/tablets segment accounts for the largest share of United States Hospital and Nursing Home Probiotics Market by formulation. The segment's dominance is attributed to the convenience of use, accurate dosage, and longer shelf life of capsules and tablets compared to other forms like powders or liquids. They are easier to administer in clinical settings, particularly for elderly patients in nursing homes, enhancing compliance with probiotic therapies. The versatility and efficacy of probiotics in capsule or tablet form, especially for digestive and immune health, further drive their widespread use in hospitals and nursing homes across United States.
Competitive Landscape
United States Hospital and Nursing Home Probiotics Market is fiercely competitive, with numerous companies vying for a larger market share. Major companies in the market include Danone, Nestle, Yakult Honsha, Probi AB, and Chr. Hansen Holding A/S, DuPont de Nemours Inc., BioGaia AB, Lallemand Inc., Sabinsa Corporation, and Nebraska Cultures Inc. These companies use various strategies, including increasing investments in their R&D activities, mergers and acquisitions, joint ventures, collaborations, licensing agreements, and new product and service releases to further strengthen their position in United States Hospital and Nursing Home Probiotics Market.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of United States Hospital and Nursing Home Probiotics Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in United States Hospital and Nursing Home Probiotics Market and industry insights to help decision-makers make sound strategic decisions. Further, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
Table of Contents
1. Research Framework
- 1.1. Research Objective
- 1.2. Product Overview
- 1.3. Market Segmentation
2. Executive Summary
3. United States Hospital and Nursing Home Probiotics Market Insights
- 3.1. Industry Value Chain Analysis
- 3.2. DROC Analysis
- 3.2.1. Growth Drivers
- 3.2.1.1. Rising Awareness of Gut Health
- 3.2.1.2. Antibiotic-Associated Diarrhea (AAD)
- 3.2.1.3. Infectious Disease Prevention
- 3.2.2. Restraints
- 3.2.2.1. High Costs
- 3.2.2.2. Limited Reimbursement
- 3.2.3. Opportunities
- 3.2.3.1. Aging Population
- 3.2.3.2. Improved Patient Outcomes
- 3.2.4. Challenges
- 3.2.4.1. Variable Efficacy
- 3.2.4.2. Potential Side Effects
- 3.2.1. Growth Drivers
- 3.3. Technological Advancements/Recent Developments
- 3.4. Regulatory Framework
- 3.5. Porter's Five Forces Analysis
- 3.5.1. Bargaining Power of Suppliers
- 3.5.2. Bargaining Power of Buyers
- 3.5.3. Threat of New Entrants
- 3.5.4. Threat of Substitutes
- 3.5.5. Intensity of Rivalry
4. United States Hospital and Nursing Home Probiotics Market: Marketing Strategies
5. United States Hospital and Nursing Home Probiotics Market: Pricing Analysis
6. United States Hospital and Nursing Home Probiotics Market Overview
- 6.1. Market Size & Forecast, 2019-2030
- 6.1.1. By Value (USD Million)
- 6.2. Market Share & Forecast
- 6.2.1. By Product Type
- 6.2.1.1. Dietary Supplements
- 6.2.1.2. Functional Foods & Beverages
- 6.2.1.3. Medical Foods
- 6.2.1.4. Probiotic-based Pharmaceuticals
- 6.2.2. By Formulation
- 6.2.2.1. Powder
- 6.2.2.2. Liquid
- 6.2.2.3. Capsules/Tablets
- 6.2.2.4. Others (Gels, Chewable Forms)
- 6.2.3. By Application
- 6.2.3.1. Digestive Health
- 6.2.3.2. Immune System Support
- 6.2.3.3. Antibiotic-associated Diarrhea (AAD)
- 6.2.3.4. Others
- 6.2.4. By Distribution Channel
- 6.2.4.1. Hospital Pharmacies
- 6.2.4.2. Retail Pharmacies
- 6.2.4.3. Online Stores
- 6.2.4.4. Direct Sales
- 6.2.1. By Product Type
7. Competitive Landscape
- 7.1. List of Key Players and Their Offerings
- 7.2. United States Hospital and Nursing Home Probiotics Company Market Share Analysis, 2023
- 7.3. Competitive Benchmarking, By Operating Parameters
- 7.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
8. Impact of Escalating Geopolitical Tensions on United States Hospital and Nursing Home Probiotics Market
9. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
- 9.1. Danone
- 9.2. Nestle
- 9.3. Yakult Honsha
- 9.4. Probi AB
- 9.5. Chr. Hansen Holding A/S
- 9.6. DuPont de Nemours Inc.
- 9.7. BioGaia AB
- 9.8. Lallemand Inc.
- 9.9. Sabinsa Corporation
- 9.10. Nebraska Cultures Inc
- 9.11. Other Prominent Players
10. Key Strategic Recommendations
11. Research Methodology
- 11.1. Qualitative Research
- 11.1.1. Primary & Secondary Research
- 11.2. Quantitative Research
- 11.3. Market Breakdown & Data Triangulation
- 11.3.1. Secondary Research
- 11.3.2. Primary Research
- 11.4. Breakdown of Primary Research Respondents, By Region
- 11.5. Assumptions & Limitations
*Financial information of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable.
List of Figures
- Figure 1 United States Hospital and Nursing Home Probiotics Segmentation
- Figure 2 United States Hospital and Nursing Home Probiotics Market Value Chain Analysis
- Figure 3 Company Market Share Analysis, 2023
- Figure 4 United States Hospital and Nursing Home Probiotics Market Size, By Value (USD Million), 2019-2030
- Figure 5 United States Hospital and Nursing Home Probiotics Market Share, By Product Type, By Value, 2019-2030
- Figure 6 United States Hospital and Nursing Home Probiotics Market Share, By Formulations, By Value, 2019-2030
- Figure 7 United States Hospital and Nursing Home Probiotics Market Share, By Application, By Value, 2019-2030
- Figure 8 United States Hospital and Nursing Home Probiotics Market Share, By Distribution Channel, By Value, 2019-2030
List of Tables
- Table 1 United States Hospital and Nursing Home Probiotics Market Size, By Value (USD Million), 2019-2030
- Table 2 United States Hospital and Nursing Home Probiotics Market Size, By Product Type, By Value, 2019-2030
- Table 3 United States Hospital and Nursing Home Probiotics Market Size, By Formulations, By Value, 2019-2030
- Table 4 United States Hospital and Nursing Home Probiotics Market Size, By Application, By Value, 2019-2030
- Table 5 United States Hospital and Nursing Home Probiotics Market Size, By Distribution Channel, By Value, 2019-2030
- Table 6 Danone Company Overview
- Table 7 Danone Financial Overview
- Table 8 Nestle Company Overview
- Table 9 Nestle Financial Overview
- Table 10 Yakult Honsha Company Overview
- Table 11 Yakult Honsha Financial Overview
- Table 12 Probi AB Company Overview
- Table 13 Probi AB Financial Overview
- Table 14 Chr. Hansen Holding A/S Company Overview
- Table 15 Chr. Hansen Holding A/S Financial Overview
- Table 16 DuPont de Nemours Inc. Company Overview
- Table 17 DuPont de Nemours Inc. Financial Overview
- Table 18 BioGaia AB Company Overview
- Table 19 BioGaia AB Financial Overview
- Table 20 Lallemand Inc. Company Overview
- Table 21 Lallemand Inc. Financial Overview
- Table 22 Sabinsa Corporation Company Overview
- Table 23 Sabinsa Corporation Financial Overview
- Table 24 Nebraska Cultures Inc. Company Overview
- Table 25 Nebraska Cultures Inc. Financial Overview
